研究論文

點擊數: 725

 

  1. Lee YL, Lim SW, Zheng HX,Chang WT, Nyam TE, Chio CC, Kuo JR, Wang CC. The Short-Term Effects of Isolated Traumatic Brain Injury on the Heart in Experimental Healthy Rats. Neurocrit Care. 2020 Oct;33(2):438-448(IF:3.49) (IF:532 Rank: 105/212=0.50 引用: 6 次)
  2. Chang WT, ZH Gao, SW Li, PY Liu, YC Lo, SN Wu. Characterization in Dual Activation by Oxaliplatin, a Platinum‐Based Chemotherapeutic Agent of Hyperpolarization‐Activated Cation and Electroporation‐Induced Currents. Int J Mol Sci. 2020 (IF:4.556) (IF:208 Rank: 69/297 =0.23 引用: 10 次)
  3. Chang WT, et al. Layer-specific distribution of myocardial deformation from anthracycline-induced cardiotoxicity in patients with breast cancer. Int J Cardiol. 2020 Jul 15;311:64-70 (IF:4.03) (IF:039 Rank: 61/143=0.43 引用: 15 次)
  4. Chang WT, Liu PY, Lee K, Feng YH, Wu SN. Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes. Int J Mol Sci. 2020 Feb 29;21(5) (IF:4.556) (IF:208 Rank: 69/297 =0.23 引用: 5 次)
  5. Hong CS, Chen ZC, Tang KT,Chang WT (Corresponding author). The Effectiveness and Safety between Monoplane and Biplane Imaging During Coronary Angiographies. Acta Cardiol Sin. 2020 Mar;36(2):105-110(IF:2.02) (IF:738 Rank: 125/143=0.87 引用: 5 次)
  6. Chang HY,Chang WT, Chen PW, Lin CC, Hsu CH. Pulmonary thromboembolism with computed tomography defined chronic thrombus is associated with higher mortality. Pulm Circ. 2020 May 1;10(2):2045894020905510(IF:2.205) (IF:886 Rank: 88/143=0.62 引用: 2 次)
  7. Chang WT, Ragazzi E, Liu PY, Wu SN. Effective block by pirfenidone, an antifibrotic pyridone compound (5-methyl-1-phenylpyridin-2[H-1]-one), on hyperpolarization-activated cation current: An additional but distinctive target. Eur J Pharmacol. 2020 Jun 7:173237. (IF:3.17) (IF:195 Rank: 71/279=0.25 引用: 3 次)
  8. Yu WL, Toh HS, Liao CT,Chang WT (Corresponding author).A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs. Cardiovasc Drugs Ther. 2020 Jun 17:1-10. (IF:4.069) (IF:947 Rank: 64/143=0.45 引用: 26 次)
  9. Wu NC, Chen ZC, Feng IJ, Ho CH, Chiang CY, Wang JJ,Chang WT (Corresponding author). Severe varicose veins and the risk of mortality: a nationwide population-based cohort study. BMJ Open. 2020 Jun 21;10(6):e034245. (IF:2.496) (IF:007 Rank: 86/172 =0.50 引用: 18 次)
  10. Chang WT, Feng YH, Kuo YH, Chen WY, Wu HC, Huang CT, Wang WC, Liao CT, Chen ZC. The impact of a multidisciplinary cardio-oncology programme on cardiovascular outcomes in Taiwan.
    • ESC Heart Fail. 2020 Jul 4;7(5):2135-9. (IF:3.407) (IF:612 Rank: 68/143=0.48 引用: 4 次)
  11. Chang WT, Chen ZC. Pulsatile Strangulation of the Aorta- A Rare Presentation and Etiology of Infective Endocarditis. Circ J. 2020 Aug 25;84(9):1607(IF:3.025) (IF:350 Rank: 72/143=0.50 引用: 1 次)
  12. Wu NC, Shih JY, Cheng BC, Chen ZC,Chang WT (Corresponding). Two tumors with different natures-The rare presentation of cardiac leiomyosarcoma. J Card Surg. 2020 Jul 27. (IF:1.351) (IF:778 Rank: 121/143=0.85 引用: 0 次)
  13. Chang WT, Liu PY, Gao ZH, Lee SW, Lee WK, Wu SN. Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of IK(M) or I K(DR) and in the Stimulation of I MEP. Front Pharmacol. 2020 Jul 21;11:1091. (IF:4.4) (IF:988 Rank: 50/279=0.18 引用: 22 次)
  14. Chang WT, Hughes MW, Liu PY. The impact of COVID-19 on the research and educational environment in Taiwan -forewarned is forearmed. J Formos Med Assoc. 2020 Aug 11:S0929-6646(20)30358-2. (IF:3.008) (IF:871 Rank: 61/172=0.35 引用: 1 次)
  15. Hsu LW, Chen PW,Chang WT, Lee WH, Liu PY. The Role of ROCK in Platelet-Monocyte Collaborative Induction of Thromboinflammation during Acute Coronary Syndrome. Thromb Haemost. 2020 Oct;120(10):1417-1431(IF:4.952) (IF:830 Rank: 18/78=0.23 引用: 7 次)
  16. Lee MC, Liao CT, Toh HS, Chou CC,Chang WT, Chen ZC, Wu WS, Yu T, Strong C. Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases. Cardiovasc Drugs Ther. 2020(IF:4.069) (IF:947 Rank: 64/143=0.45 引用: 3 次)
  17. Wu NC, Shih JY, Chen ZC, Cheng BC,Chang WT (Corresponding). A Huge and Asymptomatic Aortic Aneurysm Mimicking Intra-Cardiac Tumor. Acta Cardiol Sin. 2020 Sep;36(5):523-524(IF:2.02) (IF:738 Rank: 125/143=0.87 引用: 0 次)
  18. Chang WT, Liu PY, Wu SN. Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes. 2020 Oct 2;25(19):E4525 (IF:3.267) (IF: 4.927 Rank: 114/297=0.38 引用: 2 次)
  19. Chang WT, Huang TL, Chen ZC, Feng YH. The Expression of MicroRNA-21 in Bone Marrow Fluid is an Indicator of Hematological Disorders and Mortality. Asian Pac J Cancer Prev. 2020 Oct 1;21(10):2817-2821(IF:2.52) (IF:514 Rank: 120/211=0.57 引用: 1 次)
  20. Shih JY, Lin YW, Fisch S, Cheng JT, Kang NW, Hong CS, Chen ZC,Chang WT (Corresponding). Dapagliflozin Suppresses ER Stress and Improves Subclinical Myocardial Function in Diabetes: from Bedside to Bench. 2020 Oct 28:db200840 (IF:7.273) (IF: 9.305 Rank: 13/146 =0.09 引用: 20 次)
  21. Hu YN,Chang WT, Roan JN. Early bioprosthesis failure in mitral valve replacement. J Card Surg. 2020 (IF:1.351) (IF:778 Rank: 121/143=0.85 引用: 0 次)
  22. Liu PY,Chang WT(Co-first author), Wu SN. Characterization of the Synergistic Inhibition of IK(erg) and IK(DR) by Ribociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor. Int J Mol Sci. 2020 Oct 29;21(21):E8078(IF:4.556) (IF:208 Rank: 69/297 =0.23 引用: 9 次)
  23. Chang WT, Toh HS, Liao CT, Yu WL. Cardiac Involvement of COVID-19: A Comprehensive Review. Am J Med Sci. 2020 Oct 6:S0002-f9629(20)30434-1(IF:1.962) (IF:462 Rank: 70/172 =0.41 引用: 110 次)
  24. Chang WT, Lin YW, Ho CH, Chen ZC, Liu PY, Shih JY. Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients. Arch Toxicol. 2020 Nov 19(IF:5.98) (IF:168 Rank: 12/94 =0.13 引用: 22 次)
  25. Chang WT, Wu SN. Inhibitory Effectiveness of Gomisin A, a Dibenzocyclooctadiene Lignan Isolated from Schizandra chinensis, on the Amplitude and Gating of Voltage-Gated Na+ Current. Int J Mol Sci. 2020 Nov 21;21(22):8816(IF:4.556) (IF:208 Rank: 69/297=0.23 引用: 4 次)
  26. Chang WT, Lin CH, Hong CS, Liao CT, Liu YW, Chen ZC, Shih JY. The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction. J Cardiol. 2020 Nov 21:S0914-5087(20)30359-2. (IF:2.57) (IF: 115 Rank: 82/143=0.57 引用: 5 次)
  27. Chang WT, Shih JY, Lin YW, Chen ZC, Roan JN, Hsu CH. Growth differentiation factor-15 levels in the blood around the pulmonary artery is associated with hospitalization for heart failure in patients with pulmonary arterial hypertension. Pulm Circ. 2020 Nov 20;10(4):2045894020962948 (IF:2.205) (IF:886 Rank: 88/143=0.62 引用: 3 次)
  28. Chang WT, Liu PY, Wu SN. High Capability of Pentagalloylglucose (PGG) in Inhibiting Multiple Types of Membrane Ionic Currents. Int J Mol Sci. 2020 Dec 9;21(24):E9369 (IF:4.556) (IF:208 Rank: 69/297=0.23 引用: 3 次)
  29. Chang WT, NC Wu, JY Shih, et al. Right ventricular reserve post mitral valve repair is associated with heart failure hospitalization. Pulm Circ. December 13, 2020 (IF:2.205) (IF:886 Rank: 88/143=0.62 引用: 3 次)
  30. Liao CT, Chang WT, Yu WL, Toh HS. Management of acute cardiovascular events in patients with COVID-19. Rev Cardiovasc Med. 2020 Dec 30;21(4):577-581 (IF:0.739) (IF:430 Rank: 58/143=0.41 引用: 8 次)
  31. Chang WT, Wu SN. Effectiveness of Columbianadin, a Bioactive Coumarin Derivative, in Perturbing Transient and Persistent INa. .Int J Mol Sci. 2021 Jan 9;22(2):E621. (IF:4.556) (IF:208 Rank: 69/297=0.23 引用: 8 次)
  32. Li YC, Shen TY, Chen CC, Chang WT, Lee PY, Huang CC. Automatic Detection of Atherosclerotic Plaque and Calcification from Intravascular Ultrasound Images by Using Deep Convolutional Neural Networks. IEEE Trans Ultrason Ferroelectr Freq Control. 2021 Jan 18;PP. (IF:3.556) (IF: 267 Rank: 9/32=0.28 引用: 25 次)
  33. Yu WL, Toh HS, Liao CT, Chang WT (Corresponding author). Cardiovascular Complications of COVID-19 and Associated Concerns: A Review. Acta Cardiol Sin. 2021 Jan;37(1):9-17(IF:2.02) (IF:738 Rank: 125/143=0.87 引用: 14 次)
  34. Liao CT, Chen ZC, Chang WT (Corresponding author).The Impact of COVID-19 on Elective Cardiovascular Procedures in Taiwan - A Single-Center Experience. Acta Cardiol Sin. 2021 Jan;37(1):97-99(IF:2.02) (IF:738 Rank: 125/143=0.87 引用: 0 次)
  35. Lin CH, Chen PS, Lin CC, Chen ZC, Chang WT (Corresponding author). Giant Cell Myocarditis Presenting with Predominant Right Ventricular Dysfunction Treated Successfully with Heart Transplantation. Acta Cardiol Sin. 2021 Jan;37(1):108-11(IF:2.02) (IF:738 Rank: 125/143=0.87 引用: 0 次)
  36. Chang WT, Fisch S, Dangwal S, Mohebali J, Fiedler AG, Chen M, Hsu CH, Yang Y, Qiu Y, Alexander KM, Chen FY, Liao R. MicroRNA-21 regulates right ventricular remodeling secondary to pulmonary arterial pressure overload. J Mol Cell Cardiol. 2021 Feb 3:S0022-2828(21)00021-3. (IF:4.13) (IF:763 Rank: 45/143=0.31 引用: 4 次)
  37. Chang WT, Fisch S, Dangwal S, Chen M, Cheng S, Chen ZC, Liao R. Angiotensin II blockers improve cardiac coronary flow under hemodynamic pressure overload. Hypertens Res. 2021 Feb 10(IF:525 Rank: 18/67=0.27 引用: 3 次)
  38. Lin YW, Chen CY, Shih JY, Cheng BC, Chang CP, Lin MT, Ho CH, Chen ZC, Fisch S, Chang WT. Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation-Induced Myocardial Dysfunction. J Am Heart Assoc. 2021 Mar 20:e019274(IF:107 Rank: 42/143=0.29 引用: 17 次)
  39. Chang WT, Wu SN. Effective Activation of BKCaChannels by QO-40 (5-(Chloromethyl)-3-(Naphthalen-1-yl)-2-(Trifluoromethyl)Pyrazolo [1,5-a]pyrimidin-7(4H)-one), Known to Be an Opener of KCNQ2/Q3 Channels. Pharmaceuticals (Basel). 2021 Apr 21;14(5):388(IF:215 Rank: 16/63=0.25 引用: 3 次)
  40. Chang WT, Shih JY, Hong CS, Lin YW, Chen YC, Ho CH, Chen ZC, Roan JN, Hsu CH. Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension. ESC Heart Fail. 2021 May 6. doi: 10.1002/ehf2.13410. Online ahead of print. (已申請) (IF:612 Rank: 68/143=0.48 引用: 2次)
  41. Chang WT, Wu SN. Characterization of Direct Perturbations on Voltage-Gated Sodium Current by Esaxerenone, a Nonsteroidal Mineralocorticoid Receptor Blocker. 2021 May 13;9(5):549(IF: 4.757 Rank: 111/322=0.34 引用: 16 次)
  42. CY Chiang….WT Chang (Corresponding author) Effects of renal impairment on cardiac remodeling and clinical outcomes after myocardial infarction. J. Med. Sci. 2021, 18(13): 2842-2848. doi: 10.7150/ijms.61891(IF: 3.642 Rank: 64/172=0.37 引用: 2 次)
  43. IC Chen, WT Chang…et al. Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation. Medicine (Baltimore) 2021 Jun 11;100(23):e26272 (IF:817 Rank: 123/172=0.72 引用: 6次)
  44. WT Chang (Corresponding author). The impact of COVID-19 on Cardio-Oncology Care in Taiwan. J Formos Med Assoc. 2021 Aug 23:S0929-6646(21)00396-X. (IF:871 Rank: 56/329=0.17 引用: 0 次)
  45. Chang WT, Chen PW, Lin HW, Lin SH, Li YH. Risks of trastuzumab-related cardiotoxicity in breast cancer patients in Taiwan. ESC Heart Fail. 2021 Sep 4. doi: 10.1002/ehf2.13591(IF:612 Rank: 68/143=0.48 引用: 3 次)
  46. Wang I-Chieh, Huang H, Chang WT, Huang CC. Wall shear stress mapping for human femoral artery based on ultrafast ultrasound vector Doppler estimations. Med Phys. 2021 Sep 15. (IF:506 Rank: 45/136=0.33 引用: 3 次)
  47. Gupta S, …. Chang WT….et al. Acute kidney injury in patients treated with immune checkpoint inhibitors. ICPi-AKI Consortium. J Immunother Cancer. 2021 Oct;9(10):e003467 (IF:13.75) (IF:485 Rank: 18/162=0.11 引用: 3 次)
  48. Liao CT, Yang CT, Toh HS, Chang WT…et al. Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific region. Cardiovasc Diabetol. 2021 Oct 9;20(1):204. (IF:9.95) (IF:949 Rank: 20/143=0.14 引用: 8 次) 
  49. Liao CT, Yang CT, Kuo FH, Lee MC, Chang WT, et al. Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region. Front Cardiovasc Med. 2021 Oct 29;8:750381 (IF:848 Rank: 43/143=0.30 引用: 12 次)
  50. Chang WT, Lin YW, Chen ZC, Liu PY. The S Protein of SARS-CoV-2 Injures Cardiomyocytes Indirectly through the Release of Cytokines Instead of Direct Action. Acta Cardiol Sin. 2021 Nov;37(6):643-647(IF:738 Rank: 125/143=0.87 引用: 1 次)
  51. Kan WC, Hsieh KL,…Chang WT (Corresponding author). Comparison of Surgical or Medical Castration-Related Cardiotoxicity in Patients with Prostate Cancer. J Urol. 2021 Dec 2:101097JU0000000000002340(IF:641 Rank: 10/90=0.11 引用: 1 次)
  52. Wang IJ, Chang WT, Wu WH, Lin BS. Applying Noncontact Sensing Technology in the Customized Product Design of Smart Clothes Based on Anthropometry. Sensors (Basel). 2021 Nov 29;21(23):7978(IF:847 Rank: 29/87=0.33 引用: 4 次)
  53. Chang WT, Feng YH, Chen ZC, Wu YW. Narrative review—cardiovascular evaluation before radiotherapy for patients with breast cancer and other malignancies. Ther Radiol Oncol 2021;5:24
  54. Wu NC…. Chang WT (Corresponding author). Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities. Acta Cardiol Sin. 2022 Jan;38(1):39-46(IF:738 Rank: 125/143=0.87 引用: 0 次)|
  55. Lu LS, Wu YW, Chang TC, Chang WT….et al. Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2021 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC). Acta Cardiol Sin. 2022 Jan;38(1):1-12. (IF:738 Rank: 125/143=0.87 引用: 1 次)
  56. Huang H, Chang WT, Huang CC. High-Spatiotemporal-Resolution Visualization of Myocardial Strains Through Vector Doppler Estimation: A Small-Animal Study. IEEE Trans Ultrason Ferroelectr Freq Control. 2022 Feb 2;PP. (IF: 267 Rank: 9/32=0.28 引用: 0 次)
  57. Chang WT….Hsu CH. Dynamic Changes in miR-21 Regulate Right Ventricular Dysfunction in Congenital Heart Disease-Related Pulmonary Arterial Hypertension. Cells. 2022;11(3):564(IF:666 Rank: 51/195=0.26 引用: 0 次)
  58. Hong CS….Chang WT (Corresponding author). Association of gonadotropin-releasing hormone therapies with venous thromboembolic events in patients with prostate cancer: A national cohort study. Frontiers in Cardiovascular Medicine. 2022 (accepted) (IF:848 Rank: 43/143=0.30 引用: 1 次)
  59. Chang WT, Chen PW, Lin HW, Kuo YH, Lin SH, Li YH. Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia. Cancers (Basel). 2022 Jan 20;14(3):508. (刊登費)
  60. Chang WT et al. The impact of Sildenafil on ischemic outcomes in patients with pulmonary hypertension – a nationwide cohort study. Acta Cardiologica Sinica. 2022 Sep;38(5):623-630(IF:738 Rank: 125/143=0.87 引用: 0 次)
  61. Chang WT et al. Future perspectives of pulmonary hypertension treatment" Acta Cardiologica Sinica. 2022(IF:738 Rank: 125/143=0.87 引用: 4 次)
  62. Chang WT et al. Deletion of miR-21 impairs neovascularization following limb ischemia: from bedside to bench. Frontiers in Cardiovascular Medicine. 2022(IF:848 Rank: 43/143=0.30 引用: 3 次)
  63. Chang WT et al. Dapagliflozin Protects Against Doxorubicin-induced Cardiotoxicity by Restoring STAT3. Archives of Toxicology. 2022(IF:168 Rank: 12/94=0.13 引用: 7 次)
  64. Chang WT, et al. MiR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts. Aging (Albany NY). 2022(IF:955 Rank: 72/195=0.37 引用: 0 次)
  65. Chang HY, Chen PW, Chang WT, Yeh JK, Liu PY, Hsu CH, Lin CC. Evolutionary changes in thrombus features on computed tomography-an effective approach for identifying subacute pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2022 Aug 9:S2213-333X(22)00343-2(IF:190 Rank: 28/67=0.42 引用: 0 次)
  66. Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, et al. Acute Kidney Injury in Patients Receiving Pembrolizumab Combination Therapy versus Pembrolizumab Monotherapy for Advanced Lung Cancer. Kidney Int. 2022 Aug 11:S0085-2538(22)00611-1(IF:998 Rank: 3/90=0.03 引用: 3 次)
  67. Chang WT, Lin YW, Chen CY, Chen ZC, Shih JY, Wu CC, Luo CY, Liu PY. Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction. 2022 Sep 3;11(17):2750(IF: 7.666 Rank: 51/195=0.26 引用: 0 次)
  68. Lee MC, Liao CT, Feng IJ, Yu T, Chang WT, et al. Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis. Medicine (Baltimore). 2022 Sep 16;101(37):e30412(IF:666 Rank: 51/195=0.26 引用: 0 次)
  69. Chang WT, Hong CS, Hsieh KL, Chen YC, Ho CH, Shih JY, Kan WC, Chen ZC, Lin YC. Regular use of aspirin is associated with a lower cardiovascular risk in prostate cancer patients receiving gonadotropin-releasing hormone therapy. Front Oncol. 2022 Sep 12;12:952370. (IF:738 Rank: 78/245=0.32 引用: 0 次)
  70. Liao CT, Toh HS, Yang CT, Hsu CY, Lee MC, Chang WT, et al. Economic evaluation of new blood pressure target for hypertensive patients in Taiwan according to the 2022 hypertension clinical practice guidelines of the Taiwan society of cardiology: a simulation modeling study. Hypertens Res. 2022 Oct 14(IF:525 Rank: 18/67=0.27 引用: 1 次)
  71. Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis. Lin YM, Lee MC, Toh HS, Chang WT, et al. Ann Intensive Care. 2022 Dec 13;12(1):112(IF:318 Rank: 6/35=0.17 引用: 1 次)
  72. Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan. Lin PL, Wu YW, Lin CF, Yeh HI, Chang WT, et al. J Atheroscler Thromb. 2022 Nov 24(IF:399 Rank: 27/67=0.40 引用: 1 次)
  73. Lee MC, Hua YM, Yang CT, Kuo FH, Chang WT, et al. Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials. Medicine (Baltimore). 2022 Dec 23;101(51):e32489(IF:666 Rank: 51/195=0.26 引用: 0 次)
  74. Chao CM, Wang LY, Huang CC, Chang WT, Tang LY, Lin MT, Chang CP. Myocardial structure and functional alterations in a preclinical model of exertional heat stroke. Life Sci. 2023 Mar 31;323:121640. doi: 10.1016/j.lfs.2023.121640
  75. Chang WT, Sun CK, Wu JY, Huang PY, Liu TH, Chang YJ, Lin YT, Kang FC, Hung KC. Association of prognostic nutritional index with risk of contrast induced nephropathy: A meta-analysis. Front Nutr. 2023 Mar 23;10:1154409. doi: 10.3389/fnut.2023.1154409
  76. Chang WT, Lin HW, Lin SH, Li YH. Association of statin use with cancer- and non-cancer-associated survival in patients with breast cancer in Asia. JAMA Network Open. 2023 Apr 3;6(4):e239515 (IF:13.35) (IF:360 Rank: 15/172=0.09)
  77. Chang WT, Lin HW, Lin SH, Li YH. The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan. Front Oncol. 2023 Apr 17;13:1172036.
  78. Chang WT, Lin HW, Chang TC, Lin SH, Li YH. Assessment of tyrosine kinase inhibitors on the survival and cardiovascular outcomes of patients with non-small cell lung cancer in Taiwan. JAMA Network Open. 2023 May 1;6(5):e2313824
  79. Lee WC, Chang WT, et al. Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy. Front Biosci (Landmark Ed). 2023 Apr 27;28(4):81.
  80. Liao CT, Toh HS, Chang WT, et al. Assessment of subclinical cardiac dysfunction by speckle-tracking echocardiography among people living with human immunodeficiency virus. Front Cardiovasc Med. 2023 May 23;10:1200418
  81. Wang CC, Chang WT, et al. 2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis. Acta Cardiol Sin. 2023 Jul;39(4):511-543
  82. Chang WT, Wu CC, Liao IC, Lin YW, Chen YC, Ho CH, Lee WC, Lin YC, Chen ZC, Shih JY, Wu NC, Kan WC. Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway-A translational study. Free Radic Biol Med. 2023 Aug 5;208:103-111
  83. Chang WT, Sun CK, Wu JY, Yu CH, Chang YJ, Lin MC, Lan KM, Chen IW, Hung KC. Association of prognostic nutritional index with long-term mortality in patients receiving percutaneous coronary intervention for acute coronary syndrome: a meta-analysis. Sci Rep. 2023 Aug 11;13(1):13102
  84. Cheng PN, Chen WJ, Hou CJ, Lin CL, Chang ML, Wang CC, Chang WT, et al. TASL-TSOC Taiwan Position Statement for the Management of Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Diseases. Clin Mol Hepatol. 2023 Oct 4.
  85. Chang WT, Lin CH, Lee WC, Kan WC, Lin YC, Hiremath P, Cheng S, Liao R, Chen ZC, Huang PS, Wu NC. Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome. Int J Cardiol. 2024 Jan 1;394:131367
  86. Lee WC, Lin YW, Shih JY, Chen ZC, Wu NC, Chang WT(Corresponding). Ivabradine could not decrease mitral regurgitation triggered atrial fibrosis and fibrillation compared with carvedilol. ESC Heart Fail. 2023 Nov 14
  87. Chang WT, Lee WC, Lin YW, Shih JY, Hong CS, Chen ZC, Chu CY, Hsu CH. Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease-Related Pulmonary Arterial Hypertension. J Am Heart Assoc. 2023 Dec 5;12(23):e031435
  88. Chang WT, Liu CC, Huang YT, Wu JY, Tsai WW, Hung KC, Chen IW, Feng PH. Diagnostic efficacy of the triglyceride-glucose index in the prediction of contrast-induced nephropathy following percutaneous coronary intervention. Front Endocrinol (Lausanne). 2023 Nov 22;14:1282675
  89. Chang WT, Huang PS, Su LW, Liao CT, Toh HS, Chen YC, Ho CH, Chen ZC, Hsu PC, Hong CS. Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions. J Atheroscler Thromb. 2023 Dec 12
  90. Lu CY, Kao CL, Hung KC, Wu JY, Hsu HC, Yu CH, Chang WT, Feng PH, Chen IW. Diagnostic efficacy of serum presepsin for postoperative infectious complications: a meta-analysis. Front Immunol. 2023 Dec 12;14:1320683
  91. Chong JH, Chang WT, Chan JJ, Tan TJY, Chan JWK, Wong M, Wong FY, Chuah CTH. The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction - A systematic review. Curr Probl Cardiol. 2024 Jan 27;49(3):102372. doi: 10.1016/j.cpcardiol.2024.102372. Online ahead of print.PMID: 38281354
  92. Tseng HL, Li ZY, Lin CC, Chang WT, Shih JY, Chen ZC, Lin HJ, Liao CT. Impact of the Integrated Activation System on Door-to-Balloon Times and Clinical Outcomes in STEMI Patients Receiving Primary PCI. Acta Cardiol Sin. 2024 Jan;40(1):97-110
  93. Patil D, Tang HJ, Kuo FH, Toh HS, Yang IN, Chang WT, Lee MC, Chung KN, Huang CY, Hsu WH, Chang TC, Shih JY, Liao CT. Assessing the diversity and determinants of health-related quality of life measures in patients with acute heart failure. ESC Heart Fail. 2024
  94. Chen CY, Chang WT, Lin HW, Lin SH, Li YH. Statin Use Is Associated With Reduced Heart Failure and Risk of Death in Non-Hodgkin Lymphoma. JACC CardioOncol. 2024 Feb 20;6(1):133-135
  95. Lee WC, Chang WT, Fang HY, Chen HC, Chen MC, Liu PY. Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pacing: A Retrospective Study of 461 Cases from 2012 to 2020. Med Sci Monit. 2024 May 22;30:e944114
  96. Yang CH, Huang H, Lee PY, Chuang YH, Chang WT, Huang CC. Increasing the Maximum Detectable Flow Velocity in High-Frequency Ultrasound Vector Doppler Imaging. IEEE Trans Biomed Eng. 2024 Jul 1;PP
  97. Chang WT, Lin BS, Tsai WL, Chen HY, Liu C, Lin BS. Design of 12-Lead Electrocardiogram Smart Clothing Based on Capacitive Sensing Technique. IEEE SENSORS JOURNAL. 2024
  98. Lee WC, Chang WT, Shih JY, Wu PJ, Fang CY, Chen HC, Fang YN, Fang HY. Impact of chronic kidney disease on left atrial appendage occlusion: A meta-analysis of procedural outcomes and complications. Medicine (Baltimore). 2024 Jul 19;103(29):e38935.
  99. Huang CC, Chen TH, Ho CH, Chen YC, Chang WT, Hsu CC, Lin HJ, Chang CP, Guo HR. Hypothyroidism following carbon monoxide poisoning: An epidemiological study supported by animal experiments. Ecotoxicol Environ Saf. 2024 Jul 24;283:116772
  100. Yang IN, Huang CY, Yang CT, Toh HS, Chang WT, Su LW, Lin YM, Wang MC, Wang HY, Liao CT. Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysis. Front Cardiovasc Med. 2024 Jul 22;11:1393440
  101. Chang WT, Lin YW, Chen CY, Hong CS, Chen ZC, Lin YC, Shih JY. The combination of valsartan and spironolactone mitigated mitral regurgitation induced cardiac dysfunction in a novel rat model. J Cardiovasc Pharmacol. 2024 Jul 24
  102. Lee WC, Lin YW, Shih JY, Chen ZC, Wu NC, Chang WT (Co-corresponding), Liu PY. Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model. Biomol Biomed. 2024 Nov 28
  103. Lin CY, Chang WT, Su PL, Kuo CW, Yang J, Lin CC, Lin SH. Cardiac Events and Survival in Patients With EGFR-Mutant Non-Small Cell Lung Cancer Treated With Osimertinib. JAMA Netw Open. 2024 Dec 2;7(12):e2448364
  104. Hung CL, Wu YW, Kuo L, Sung KT, Lin HH, Chang WT, Chang CH, Lai CH, Huang CY, Wang CL, Lin CC, Juang JJ, Chen PS, Wang CY, Chang HC, Chu CY, Wang WH, Tseng H, Kao YT, Wang TD, Yu WC, Chen WJ. 2024 Update of the TSOC Expert Consensus of Fabry Disease. Acta Cardiol Sin. 2024 Sep;40(5):544-568.
  105. Chao TH, Lin TH, Cheng CI, Wu YW, Ueng KC, Wu YJ, Lin WW, Leu HB, Cheng HM, Huang CC, Wu CC, Lin CF, Chang WT, Pan WH, Chen PR, Ting KH, Su CH, Chu CS, Chien KL, Yen HW, Wang YC, Su TC, Liu PY, Chang HY, Chen PW, Juang JJ, Lu YW, Lin PL, Wang CP, Ko YS, Chiang CE, Hou CJ, Wang TD, Lin YH, Huang PH, Chen WJ. 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I. Acta Cardiol Sin. 2024 Sep;40(5):479-543
  106. Lee MC, Wu JY, Yu T, Liao CT, Chang WT, Toh HS, Hung KC, Su HC. Clinical Efficacy and Safety of Novel Anticoagulants for the Management of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2024 Oct 21
  107. Lee WC, Hong CS, Chang WT, Liao CT, Huang PS, Huang SC, Lin CH, Chiang CY, Chen ZC, Shih JY. Efficacy and Safety of Direct Oral Anticoagulants After Mechanical Thrombectomy in Venous Thromboembolism: A Comparative Study of 55 Patients. Med Sci Monit. 2024 Nov 25;30:e946362
  108. Chao TH, Lin TH, Cheng CI, Wu YW, Ueng KC, Wu YJ, Lin WW, Leu HB, Cheng HM, Huang CC, Wu CC, Lin CF, Chang WT, Pan WH, Chen PR, Ting KH, Su CH, Chu CS, Chien KL, Yen HW, Wang YC, Su TC, Liu PY, Chang HY, Chen PW, Juang JJ, Lu YW, Lin PL, Wang CP, Ko YS, Chiang CE, Hou CJ, Wang TD, Lin YH, Huang PH, Chen WJ. 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part II. Acta Cardiol Sin. 2024 Nov;40(6):669-715
  109. Lin YC, Shih JY, Lin YW, Niu KC, Hong CS, Chen ZC, Pan SC, Chang TY, Kan WC, Chang WT (Corresponding author). Hyperbaric Oxygen Therapy Improved Neovascularisation Following Limb Ischaemia-The Role of ROS Mitigation. J Cell Mol Med. 2024 Dec;28(24):e70310
列印